Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.6 - $11.69 $99,926 - $208,596
-17,844 Reduced 14.87%
102,156 $604,000
Q1 2024

May 14, 2024

SELL
$5.05 - $10.0 $686,699 - $1.36 Million
-135,980 Reduced 53.12%
120,000 $1.09 Million
Q4 2023

Feb 14, 2024

BUY
$1.65 - $6.85 $392,488 - $1.63 Million
237,872 Added 1313.63%
255,980 $1.53 Million
Q1 2022

May 16, 2022

BUY
$2.96 - $8.8 $53,599 - $159,350
18,108 New
18,108 $69,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $241M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.